We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Recordati S.p.A. (Symbol:REC) SWOT Analysis, Strategy, Revenues and Profits

Recordati S.p.A. (Symbol:REC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Recordati S.p.A. SWOT Analysis report provides you a strategic analysis ...

Industries: Drug and Medication | Countries: Czech Republic, Italy, Europe

EU: Heterocyclic Compounds - Market Report. Analysis and Forecast to 2020

EU: Heterocyclic Compounds - Market Report. Analysis and Forecast to 2020

  • $ 2 161
  • Industry report
  • by IndexBox Marketing
  • November 2014

The report provides an in-depth analysis of the EU Market of Heterocyclic Compounds. It presents the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnover in the industry. The report shows the sales data, allowing you to identify the key drivers ...

Industries: Drug and Medication | Countries: Europe, Czech Republic, United Kingdom, Netherlands, Luxembourg, Lithuania, World, Sweden, Spain, Slovenia, Slovakia (slovak Republic), Romania, Portugal, Poland, Malta, Latvia, Italy, Ireland, Hungary, Greece, France, Germany, Finland, Estonia, Denmark, Cyprus, Croatia, Bulgaria, Belgium, Austria

EU: Lactams From Heterocyclic Compounds - Market Report. Analysis and Forecast to 2020

EU: Lactams From Heterocyclic Compounds - Market Report. Analysis and Forecast to 2020

  • $ 2 161
  • Industry report
  • by IndexBox Marketing
  • November 2014

The report provides an in-depth analysis of the EU Market of Lactams From Heterocyclic Compounds. It presents the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnover in the industry. The report shows the sales data, allowing you to identify ...

Industries: Drug and Medication | Countries: Europe, Czech Republic, United Kingdom, Netherlands, Luxembourg, Lithuania, World, Sweden, Spain, Slovenia, Slovakia (slovak Republic), Romania, Portugal, Poland, Malta, Latvia, Italy, Ireland, Hungary, Greece, France, Germany, Finland, Estonia, Denmark, Cyprus, Croatia, Bulgaria, Belgium, Austria

EU: Hormones, Prostaglandins, Thromboxanes And Leukotrienes - Market Report. Analysis and Forecast to 2020

EU: Hormones, Prostaglandins, Thromboxanes And Leukotrienes - Market Report. Analysis and Forecast to 2020

  • $ 2 161
  • Industry report
  • by IndexBox Marketing
  • November 2014

The report provides an in-depth analysis of the EU Market of Hormones, Prostaglandins, Thromboxanes And Leukotrienes. It presents the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnover in the industry. The report shows the sales data, allowing ...

Industries: Drug and Medication | Countries: Europe, Czech Republic, United Kingdom, Netherlands, Luxembourg, Lithuania, World, Sweden, Spain, Slovenia, Slovakia (slovak Republic), Romania, Portugal, Poland, Malta, Latvia, Italy, Ireland, Hungary, Greece, France, Germany, Finland, Estonia, Denmark, Cyprus, Croatia, Bulgaria, Belgium, Austria

EU: Antibiotics - Market Report. Analysis and Forecast to 2020

EU: Antibiotics - Market Report. Analysis and Forecast to 2020

  • $ 2 161
  • Industry report
  • by IndexBox Marketing
  • November 2014

The report provides an in-depth analysis of the EU Market of Antibiotics. It presents the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnover in the industry. The report shows the sales data, allowing you to identify the key drivers and restraints. ...

Industries: Drug and Medication | Countries: Europe, Czech Republic, United Kingdom, Netherlands, Luxembourg, Lithuania, World, Sweden, Spain, Slovenia, Slovakia (slovak Republic), Romania, Portugal, Poland, Malta, Latvia, Italy, Ireland, Hungary, Greece, France, Germany, Finland, Estonia, Denmark, Cyprus, Croatia, Bulgaria, Belgium, Austria

EU: Vaccines For Human Medicine - Market Report. Analysis and Forecast to 2020

EU: Vaccines For Human Medicine - Market Report. Analysis and Forecast to 2020

  • $ 2 161
  • Industry report
  • by IndexBox Marketing
  • November 2014

The report provides an in-depth analysis of the EU Market of Vaccines For Human Medicine. It presents the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnover in the industry. The report shows the sales data, allowing you to identify the key ...

Industries: Drug and Medication | Countries: Europe, Czech Republic, United Kingdom, Netherlands, Luxembourg, Lithuania, World, Sweden, Spain, Slovenia, Slovakia (slovak Republic), Romania, Portugal, Poland, Malta, Latvia, Italy, Ireland, Hungary, Greece, France, Germany, Finland, Estonia, Denmark, Cyprus, Croatia, Bulgaria, Belgium, Austria

Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • October 2014
  • 109 pages

BMI View: Our expectations that the Czech Republic would return to moderately positive growth in 2011, before seeing negligible growth in 2012 have been revised downwards, and we now project very low growth for the current year as well as 2012. Despite this downward revision, BMI maintains that relatively ...

Industries: Drug and Medication | Countries: Czech Republic

Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • July 2014
  • 112 pages

BMI View: In response to the expected passage of key drug policy reforms in the Czech Republic, BMI has cut its projections for pharmaceutical industry growth in 2012 to 0.0%, with the prospects of lower prices, difficult industry entry and increased generic substitution the major contributing factors. ...

Industries: Drug and Medication | Countries: Czech Republic

NRT Smoking Cessation Aids in the Czech Republic

NRT Smoking Cessation Aids in the Czech Republic

  • $ 898
  • Industry report
  • by Euromonitor International
  • June 2014
  • 19 pages

While the number of smokers in the Czech Republic remains relatively stable, more and more consumers are pledging to give up smoking. Out of those who do, only approximately 20% of them succeed in quitting smoking. Czechs are starting to smoke at a younger age and smoking is very common at secondary ...

Industries: Drug and Medication, Tobacco | Countries: Czech Republic

Analgesics Market Analysis in the Czech Republic

Analgesics Market Analysis in the Czech Republic

  • $ 898
  • Industry report
  • by Euromonitor International
  • June 2014
  • 22 pages

The Analgesics in Czech Republic report offers a comprehensive guide to the size and shape of the industry at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the segments driving growth. It identifies the leading firms , the leading brands and offers strategic ...

Industries: Drug and Medication | Countries: Czech Republic

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.